Literature DB >> 31696486

MiR-223-3p promotes the growth and invasion of neuroblastoma cell via targeting FOXO1.

L-L Han1, X-J Zhou, F-J Li, X-W Hao, Z Jiang, Q Dong, X Chen.   

Abstract

OBJECTIVE: MicroRNAs (miRNAs) have been demonstrated to have crucial roles in cancer development. We investigated the involvement of miR-223-3p in neuroblastoma (NB).
MATERIALS AND METHODS: MiR-223-3p expression in NB cell lines and normal cell line was analyzed with real-time quantitative PCR method. Cell proliferation, cell invasion, and cell apoptosis were assessed by cell counting kit-8 (CCK-8), transwell invasion assay, and flow cytometry assay, respectively. Bioinformatics analysis, Dual-Luciferase reporter assays, and Western blot analysis were conducted to identify the connection of miR-223-3p and forkhead box O1 (FOXO1).
RESULTS: MiR-223-3p level was found highly expressed in NB cell lines compared with normal cell line. Knockdown miR-223-3p expression decreased cell growth and invasion but increased cell apoptosis. MiR-223-3p was able to bind with the 3'-untranslated region of FOXO1, and thereby resulting in a reduction of FOXO1 expression. The knockdown of FOXO1 increased the malignant capacity of NB cells.
CONCLUSIONS: Therefore, given the fact that miR-223-3p suppressed FOXO1 expression to promote NB progression, targeting miR-223-3p may be an effective method for NB treatment.

Entities:  

Year:  2019        PMID: 31696486     DOI: 10.26355/eurrev_201910_19298

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

1.  MiR-223-3p-loaded exosomes from bronchoalveolar lavage fluid promote alveolar macrophage autophagy and reduce acute lung injury by inhibiting the expression of STK39.

Authors:  Nan He; Haoyu Tan; Xueyu Deng; Lu Shu; Bei Qing; Hengxing Liang
Journal:  Hum Cell       Date:  2022-08-06       Impact factor: 4.374

Review 2.  Emerging therapeutic targets for neuroblastoma.

Authors:  Natarajan Aravindan; Terence Herman; Sheeja Aravindan
Journal:  Expert Opin Ther Targets       Date:  2020-10-06       Impact factor: 6.902

3.  MiR-542-3p Suppresses Neuroblastoma Cell Proliferation and Invasion by Downregulation of KDM1A and ZNF346.

Authors:  Qiang Wei; Zhao Guo; Dong Chen; Xinjian Jia
Journal:  Open Life Sci       Date:  2020-04-10       Impact factor: 0.938

4.  MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.

Authors:  Minjiang Huang; Ti Zhang; Zhi-Yong Yao; Chaoqung Xing; Qingyi Wu; Yuan-Wu Liu; Xiao-Liang Xing
Journal:  BMC Med Genomics       Date:  2021-03-09       Impact factor: 3.063

5.  Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction.

Authors:  Manish Muhuri; Wei Zhan; Yukiko Maeda; Jia Li; Anoushka Lotun; Jennifer Chen; Katelyn Sylvia; Ishani Dasgupta; Motahareh Arjomandnejad; Thomas Nixon; Allison M Keeler; Sangeetha Manokaran; Ran He; Qin Su; Phillip W L Tai; Guangping Gao
Journal:  Front Immunol       Date:  2021-04-28       Impact factor: 8.786

6.  Circ_ZFR affects FABP7 expression to regulate breast cancer progression by acting as a sponge for miR-223-3p.

Authors:  Xiuling Tian; Hong Yang; Qian Fang; Hongmei Quan; Hongyu Lu; Xin Wang
Journal:  Thorac Cancer       Date:  2022-03-30       Impact factor: 3.223

7.  Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.

Authors:  Ting Liu; Li Yuan; Xiaofeng Zou
Journal:  J Ovarian Res       Date:  2022-08-14       Impact factor: 5.506

8.  miR-223-3p Regulates NLRP3 to Inhibit Proliferation and Promote Apoptosis of ONG Cells.

Authors:  Lili Nie; Hui Zou; Chi Ma; Xiaoke Wang
Journal:  Comput Math Methods Med       Date:  2022-10-04       Impact factor: 2.809

9.  LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.

Authors:  Niansheng Ren; Tao Jiang; Chengbo Wang; Shilin Xie; Yanwei Xing; Daxun Piao; Tiemin Zhang; Yuekun Zhu
Journal:  Aging (Albany NY)       Date:  2020-06-09       Impact factor: 5.682

10.  miR-223-3p targets FBXW7 to promote epithelial-mesenchymal transition and metastasis in breast cancer.

Authors:  Yuli Wang; Shuang Shi; Yunshan Wang; Xuhua Zhang; Xiaoyan Liu; Juan Li; Peilong Li; Lutao Du; Chuanxin Wang
Journal:  Thorac Cancer       Date:  2021-12-24       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.